Australia - English - Department of Health (Therapeutic Goods Administration)

steriscience pty ltd - caspofungin acetate, quantity: 77.7 mg - injection, powder for - excipient ingredients: sucrose; mannitol; carbon dioxide; sodium hydroxide; dilute hydrochloric acid - casfungin is indicated for: ? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? treatment of: - invasive candidiasis, including candidaemia - oesophageal candidiasis - invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

Australia - English - Department of Health (Therapeutic Goods Administration)

steriscience pty ltd - caspofungin acetate, quantity: 55.5 mg - injection, powder for - excipient ingredients: mannitol; sucrose; carbon dioxide; sodium hydroxide; dilute hydrochloric acid - casfungin is indicated for: ? empirical therapy for presumed fungal infections in febrile, neutropenic patients whose fever has failed to respond to broad-spectrum antibiotics ? treatment of: - invasive candidiasis, including candidaemia - oesophageal candidiasis - invasive aspergillosis in patients who are refractory to or intolerant of other therapies.

United Kingdom - English - myHealthbox

3m health care ltd - salmeterol/fluticasone propionate - pressurised inhalation, suspension - 25microgram/125microgram - adrenergics and other anti-asthmatics - is indicated in the regular treatment of asthma where use of a combination product (long-acting β2 agonist and inhaled corticosteroid) is appropriate

United Kingdom - English - myHealthbox

3m health care ltd - salmeterol/fluticasone propionate - pressurised inhalation, suspension - 25microgram/250microgram - adrenergics and other anti-asthmatics - it is indicated in the regular treatment of asthma where use of a combination product (long-acting β2 agonist and inhaled corticosteroid) is appropriate

Bangladesh - English - DGDA (Directorate General of Drug Administration)

beacon pharmaceuticals ltd. - potassium bicarbonate + sodium alginate - tablet - 100 mg + 500 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

beacon pharmaceuticals ltd. - potassium bicarbonate + sodium alginate - suspension - 100 mg + 500 mg/5 ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

beacon pharmaceuticals plc - potassium bicarbonate + sodium alginate - tablet - 100 mg + 500 mg

Bangladesh - English - DGDA (Directorate General of Drug Administration)

beacon pharmaceuticals plc - potassium bicarbonate + sodium alginate - suspension - 100 mg + 500 mg/5 ml